TipRanks
BioForce Nanosciences Holdings (BFNH)
OTHER OTC:BFNH
US Market
BFNH
BioForce Nanosciences Holdings
RESEARCH TOOLSreports

BioForce Nanosciences Holdings (BFNH) Income Statement

11 Followers

BioForce Nanosciences Holdings Income Statement

Last quarter (Q2 2026), BioForce Nanosciences Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, BioForce Nanosciences Holdings's net income was $238.68K. See BioForce Nanosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 489.95K$ 490.44K$ 471.95K$ 485.51K$ 501.95K
Depreciation and Amortization
$ 0.00$ 0.00$ 471.95K$ 0.00$ 0.00
EBITDA
$ -489.95K$ -490.44K$ 0.00$ -485.51K$ -501.95K
Operating Income
$ -489.95K$ -490.44K$ -471.95K$ -485.51K$ -501.95K
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Pretax Income
$ -489.95K$ -490.44K$ -471.95K$ -485.51K$ -501.95K
Net Income
$ -1.29M$ -490.44K$ -471.95K$ -485.51K$ -501.95K
Per Share Metrics
Basic EPS
$ -0.04$ -0.02$ -0.02$ -0.02$ -0.02
Diluted EPS
$ -0.04$ -0.02$ -0.02$ -0.02$ -0.02
Weighted Average Shares Outstanding
 33.21M 29.27M 29.27M 29.27M 29.27M
Weighted Average Shares Outstanding (Diluted)
 33.21M 29.27M 29.27M 29.27M 29.27M
Currency in USD

BioForce Nanosciences Holdings Earnings and Revenue History